Imagine a cancer treatment that precisely targets malignant cells, leaving healthy ones untouched. Consider, also, a cancer treatment that corrects abnormal protein synthesis to produce healthy ...

A combination of mRNA and a new lipid nanoparticle could help heal damaged lungs, according to new research from the Perelman ...

Adding a personalized mRNA vaccine to standard treatment could offer new hope for pancreatic cancer patients, a small yet ...

The plant-editing system uses mRNA to avoid the risk that foreign DNA could be left behind and create unwanted mutations.

We recently published a list of Five Chinese Firms Dominate Friday’s Top 10 Gainers. In this article, we are going to take a look at where Moderna Inc. (NASDAQ:MRNA) stands against the other friday’s ...

As per a new study, the potential of mRNA vaccines offers a personalized treatment for patients with pancreatic cancer.

A promising new mRNA-based vaccine for pancreatic cancer has shown potential in reducing the recurrence of the disease post-surgery. MSK's phase 1 cli ...

Bullish option flow detected in Moderna (MRNA) with 76,253 calls trading, 1.4x expected, and implied vol increasing almost 8 points to 77.82%.

CoV-2, has been discovered in China and is “strikingly similar to the pandemic virus” and feared to be powerful ...

Concerns about coronavirus news out of China may have moved some vaccine-maker and travel stocks Friday.

Pancreatic cancer is the 10th deadliest form of cancer in the United States, according to the National Cancer Institute.

The move comes after Commission Chairman Clint Didier invited a group of vaccine skeptics to speak at two recent meetings. It’s the same group behind recent pushes in Idaho to stop offering the ...